Trial Profile
Clinical Application Study of Transarterial Chemoembolization Containing Arsenic Trioxide in the Treatment of Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2016
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Doxorubicin; Ethiodized oil
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SEATH
- 12 Nov 2016 Status changed from recruiting to completed.
- 09 Jun 2014 New trial record